Parsatuzumab

Parsatuzumab (INN) is a humanized monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to EGFL7.[1]

Parsatuzumab
Monoclonal antibody
TypeWhole antibody
SourceHumanized (from mouse)
TargetEGFL7
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
Chemical and physical data
FormulaC6560H10130N1758O2046S46
Molar mass147836.22 g·mol−1

This drug was developed by Genentech/Roche.[2]

References


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.